Achieve Life Sciences Q2 2025 Earnings Preview
Source: SeekingAlpha
2025-08-06 11:38:43 ET
More on Achieve Life Sciences
- Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation
- Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk
- Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript
- Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering
- Achieve Life Sciences announces proposed public offering; shares down nearly 1
Read the full article on Seeking Alpha
For further details see:
Achieve Life Sciences Q2 2025 Earnings Preview
Achieve Life Sciences Inc.
NASDAQ: ACHV
ACHV Trading
0.73% G/L:
$5.409 Last:
1,030,133 Volume:
$5.10 Open:
ACHV Latest News
May 19, 2026 02:15:00 pm
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
May 12, 2026 07:05:00 am
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
May 12, 2026 07:00:00 am
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
ACHV Stock Data
$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell
